Higher Education Access Grants (2026)

U.S. Mission to Iraq

The U.S. Embassy Baghdad Public Diplomacy Section (PDS) announces an open competition to implement English Access Microscholarship Program for Central and Southern Iraq. The Public Diplomacy Section seeks to provide Iraqi youth with educational opportunities through English-language instruction in accordance with Mission Iraq goals. English language skills are an important tool for Iraqi youth seeking access to higher education, employment, exchange programs, and broader engagement with the global community.

Florida Department of Education

State scholarship and financial aid program administered by Florida Department of Education for FL students and educational institutions.

Tennessee Student Assistance Corporation (TSAC)

State scholarship and financial aid program administered by Tennessee Student Assistance Corporation (TSAC) for TN students and educational institutions.

Georgia Student Finance Commission

State scholarship and financial aid program administered by Georgia Student Finance Commission for GA students and educational institutions.

Bureau of Justice Assistance

BJA FY25 Forensic Ballistics and Higher Education Program

Institute for Veterans and Military Families

Grants for research and programs on veteran entrepreneurship, employment, and military family well-being.

Administration on Intellectual & Developmental Disabilities

Grants to university-based centers for training, research, and service in developmental disabilities.

North Carolina State Education Assistance Authority

State scholarship and financial aid program administered by North Carolina State Education Assistance Authority for NC students and educational institutions.

National Institute of Food and Agriculture

The purpose of HEC, under assistance listing 10.217, is to strengthen institutional capacities, including curriculum, faculty, scientific instrumentation, and student recruitment and retention. The HEC program is focused on developing and improving formal master s or doctorate degree-level food and agricultural sciences education and first professional degree-level education in veterinary medicine, such as a doctorate in veterinary medicine (DVM).

Government of Canada

Vanier CGS provides $50,000/year for three years to attract and retain world-class doctoral students at Canadian universities.

Air Force Office of Scientific Research

<p>The Department of Defense (DoD) announces the Fiscal Year 2027 Defense University Research Instrumentation Program (DURIP). DURIP is designed to improve the capabilities of accredited United States (U.S.) institutions of higher education to conduct research and to educate scientists and engineers in areas important to national defense, by providing funds for the acquisition of research equipment or instrumentation. For-profit organizations are not eligible for DURIP funding.</p>

Air Force Office of Scientific Research

The Department of Defense (DoD) announces the Fiscal Year 2027 Defense University Research Instrumentation Program (DURIP). DURIP is designed to improve the capabilities of accredited United States (U.S.) institutions of higher education to conduct research and to educate scientists and engineers in areas important to national defense, by providing funds for the acquisition of research equipment or instrumentation. For-profit organizations are not eligible for DURIP funding.

Dept of the Army -- Materiel Command

Department of Army:The Department of War (DoW) announces the Fiscal Year 2027 Defense University Research Instrumentation Program (DURIP). DURIP is designed to improve the capabilities of accredited United States (U.S.) institutions of higher education to conduct research and to educate scientists and engineers in areas important to national defense, by providing funds for the acquisition of research equipment or instrumentation. For-profit organizations are not eligible for DURIP funding.

Office of Naval Research

In accordance with EO 14332, Improving Oversight of Federal Grantmaking, dated 7 August 2025, and EO 14303, Restoring Gold Standard Science, dated 23 May 2025, this Announcement seeksproposals from universities to purchase equipment and instrumentation in support of research in areas of interest to the DoW, reflecting the basic research priorities for the Department of War and advancing the administration and agency priorities (c.f., OMB memo M-25-34 Fiscal Year 2027 Administration Research and Development Budget Priorities and Cross-Cutting Actions ).DoW interests include the areas of research supported by the Army Research Office (ARO), the Office of Naval Research (ONR), and the Air Force Office of Scientific Research (AFOSR).A central purpose of the DURIP is to provide equipment and instrumentation to enhance research related education in areas of interest and priority to the DoW. Therefore, your proposal must address the impact of the equipment or instrumentation on your institution s ability to educate students through research in disciplines important to DoW missions.

Transportation Agency

UNIVERSITY OF VT & STATE AGRICULTURAL

Transportation Agency

UNIVERSITY OF VT & STATE AGRICULTURAL

U.S. National Science Foundation

Government and the nation face a talent shortfall in artificial intelligence (AI) and cybersecurity. The CyberAICorps Scholarship for Service (CyberAI SFS) program welcomes proposals that address AI and cybersecurity education and workforce development. CyberAI refers to using AI in cybersecurity as well as providing security and resilience for AI systems. The Scholarship Track provides funding to establish, or to continue, scholarship for service programs with integrated AI and cybersecurity components (CyberAI). Scholarship recipients must be U.S. citizens or lawful permanent residents and work after graduation in the AI or cybersecurity mission of a government organization for a period of at least the length of the scholarship. The Innovation Track supports projects that enhance preparation of AI and/or cybersecurity professionals. Projects may expand existing educational opportunities, curricula, degree programs, educational pathways, methods and interventions, and partnerships among institutions of higher education, government, and employers. Two statutes authorize this program: 15 USC 7442 (cybersecurity) and 42 USC 18993 (AI). CyberAI SFS aligns with the Executive Order 14277 to prioritize AI within scholarship for service programs. CyberAI is managed by NSF s Directorate for STEM Education in collaboration with the U.S. Office of Personnel Management (OPM) and U.S. Department of Homeland Security (DHS).

Air Force -- Research Lab

<p>Original Solictation:</p> <ul> <li>Closing Date of the FOA</li> <li>FROM:&nbsp;18 July 2024</li> <li>TO:&nbsp;18 July 2029</li> <li>Cost Ceiling</li> <li>$49M</li> <li>Contracting/Agreements Points of Contact (POC)</li> <li>Agreements Officer</li> <li>Mariah Salazar</li> <li>Agreements Specialist</li> <li>Monique Esquibel-Sena</li> <li>Emails: mariah.salazar@us.af.mil; monique.esquibel_sena@us.af.mil</li> </ul> <p><br></p> <p>Solicitation Amend 1:</p> <ul> <li>Closing Date of the FOA</li> <li>FROM:&nbsp;18 July 2024</li> <li>TO:&nbsp;18 July 2029</li> <li>Cost Ceiling</li> <li>$49M</li> <li>Contracting/Agreements Points of Contact (POC)</li> <li>Agreements Officer</li> <li>Mariah Salazar</li> <li>Agreements Specialist</li> <li>Monique Esquibel-Sena</li> <li>Emails: mariah.salazar@us.af.mil; monique.esquibel_sena@us.af.mil</li> </ul> <p>(Revisions made: Updated information on Mandatory Letter of Intent to allow for interested parties to submit Letters of Intent through Valid Eval portal)</p> <p><br></p> <p>Solicitation Amend 2:</p> <ul> <li>Closing Date of the FOA</li> <li>FROM:&nbsp;18 July 2024</li> <li>TO:&nbsp;18 July 2029</li> <li>Cost Ceiling</li> <li>$49M</li> <li>Contracting/Agreements Points of Contact (POC)</li> <li>Agreements Officer</li> <li>Mariah Salazar</li> <li>Agreements Specialist</li> <li>Monique Esquibel-Sena</li> <li>Emails: mariah.salazar@us.af.mil; monique.esquibel_sena@us.af.mil</li> </ul> <p>(Revisions made: Added detail for Letter of Intent Evaluation Criteria)</p> <p><br></p> <p>Solicitation Amend 3:</p> <ul> <li>Closing Date of the FOA</li> <li>FROM:&nbsp;18 July 2024</li> <li>TO:&nbsp;18 July 2029</li> <li>Cost Ceiling</li> <li>$49M</li> <li>Contracting/Agreements Points of Contact (POC)</li> <li>Agreements Officer</li> <li>Mariah Salazar</li> <li>Alternate Agreements Officer</li> <li>Jennifer Jaramillo</li> <li>Agreements Specialist</li> <li>Monique Esquibel-Sena</li> <li>Brendan Merritt</li> <li>Emails: mariah.salazar@us.af.mil; monique.esquibel_sena@us.af.mil, <span style="color: windowtext;">jennifer.jaramillo@us.af.mil</span>, brendan.merritt@us.af.mil</li> </ul> <p>(Revisions made: Changed Letter of Intent review from 10 business days to 30 business days, Added verbiage to Section, D. Review and Selection Process, on Security Risk Review, added Agreement Specialist, Brendan Merritt, brendan.merritt@us.af.mil)</p> <p><br></p> <p>Solicitation Amend 4:</p> <ul> <li>Closing Date of the FOA</li> <li>FROM:&nbsp;18 July 2024</li> <li>TO:&nbsp;18 July 2029</li> <li>Cost Ceiling</li> <li>$49M</li> <li>Contracting/Agreements Points of Contact (POC)</li> <li>Agreements Officer</li> <li>Mariah Salazar</li> <li>Alternate Agreements Officer</li> <li>Jennifer Jaramillo</li> <li>Agreements Specialist</li> <li>Monique Esquibel-Sena</li> <li>Emails: mariah.salazar@us.af.mil; monique.esquibel_sena@us.af.mil, <span style="color: windowtext;">jennifer.jaramillo@us.af.mil</span></li> </ul> <p>(Revisions made: Changed Attachment 2 of Solicitation to DoD R&amp;D General Terms and Conditions MARCH 2025. Removed Agreement Specialist, Brendan Merritt, brendan.merritt@us.af.mil)</p>

Air Force -- Research Lab

Original Solictation: Closing Date of the FOA FROM: 18 July 2024 TO: 18 July 2029 Cost Ceiling $49M Contracting/Agreements Points of Contact (POC) Agreements Officer Mariah Salazar Agreements Specialist Monique Esquibel-Sena Emails: mariah.salazar@us.af.mil; monique.esquibel_sena@us.af.mil Solicitation Amend 1: Closing Date of the FOA FROM: 18 July 2024 TO: 18 July 2029 Cost Ceiling $49M Contracting/Agreements Points of Contact (POC) Agreements Officer Mariah Salazar Agreements Specialist Monique Esquibel-Sena Emails: mariah.salazar@us.af.mil; monique.esquibel_sena@us.af.mil (Revisions made: Updated information on Mandatory Letter of Intent to allow for interested parties to submit Letters of Intent through Valid Eval portal) Solicitation Amend 2: Closing Date of the FOA FROM: 18 July 2024 TO: 18 July 2029 Cost Ceiling $49M Contracting/Agreements Points of Contact (POC) Agreements Officer Mariah Salazar Agreements Specialist Monique Esquibel-Sena Emails: mariah.salazar@us.af.mil; monique.esquibel_sena@us.af.mil (Revisions made: Added detail for Letter of Intent Evaluation Criteria) Solicitation Amend 3: Closing Date of the FOA FROM: 18 July 2024 TO: 18 July 2029 Cost Ceiling $49M Contracting/Agreements Points of Contact (POC) Agreements Officer Mariah Salazar Alternate Agreements Officer Jennifer Jaramillo Agreements Specialist Monique Esquibel-Sena Brendan Merritt Emails: mariah.salazar@us.af.mil; monique.esquibel_sena@us.af.mil, jennifer.jaramillo@us.af.mil, brendan.merritt@us.af.mil (Revisions made: Changed Letter of Intent review from 10 business days to 30 business days, Added verbiage to Section, D. Review and Selection Process, on Security Risk Review, added Agreement Specialist, Brendan Merritt, brendan.merritt@us.af.mil) Solicitation Amend 4: Closing Date of the FOA FROM: 18 July 2024 TO: 18 July 2029 Cost Ceiling $49M Contracting/Agreements Points of Contact (POC) Agreements Officer Mariah Salazar Alternate Agreements Officer Jennifer Jaramillo Agreements Specialist Monique Esquibel-Sena Emails: mariah.salazar@us.af.mil; monique.esquibel_sena@us.af.mil, jennifer.jaramillo@us.af.mil (Revisions made: Changed Attachment 2 of Solicitation to DoD R&amp;D General Terms and Conditions MARCH 2025. Removed Agreement Specialist, Brendan Merritt, brendan.merritt@us.af.mil)

Idaho Field Office

University Nuclear Leadership Program&ndash; Scholarship and Fellowship Support

Jack Kent Cooke Foundation

Funds $90M in scholarships and grants for high-achieving low-income students.

U.S. Mission to Cambodia

<p>The U.S. Department of State’s U.S. Embassy Phnom Penh announces an open competition to implement a program to strengthen ties between the Kingdom of Cambodia and the United States of America through programming that promotes U.S. interests, American excellence, and bilateral cooperation. Priority program areas may cover one or more of the following goals: (1) Freedom 250 – Commemorate the 250th Anniversary of America’s Founding; (2) Safeguarding Americans and Cambodians Against Transnational Cybercrime and Advancing U.S. Technological Leadership and Economic Interests; (3) Engaging Alumni Networks to Advance U.S. Interests; (4) Promoting U.S. Higher Education; (5) Promoting American English Language Education, and (6) Countering Malign Influence and Promoting Free Speech. All programs must include an American element or connection with American expert/s, organization/s, or institution/s in a specific field that will promote increased understanding of U.S. policies and perspectives.</p>

Governor's Office of Emergency Services

Funding provided under this Program must not be used to support prevention-focused activities or initiatives.

National Institutes of Health

The purpose of this announcement is to encourage investigators to pursue a small clinical trial to obtain critical information necessary to advance recording and/or stimulating devices to treat central nervous system disorders and better understand the human brain (e.g., Early Feasibility Study). Clinical studies supported may consist of acute or short-term procedures that are deemed Non-Significant Risk (NSR) by an Institutional Review Board (IRB), or Significant Risk (SR) studies that require an Investigational Device Exemption (IDE) from the FDA, such as chronic implants. The clinical trial should provide data to answer key questions about the function or final design of a device. This final device design may require most, if not all, of the non-clinical testing on the path to more advanced clinical trials and market approval. The clinical trial is expected to provide information that cannot be practically obtained through additional non-clinical assessments (e.g., bench top or animal studies) due to the novelty of the device or its intended use. Activities supported by this Funding Opportunity include a small clinical trial to answer key questions about the function or final design of a device.As part of the BRAIN Initiative, NIH has initiated a Public-Private Partnership Program (BRAIN PPP) that includes agreements (Memoranda of Understanding, MOU) with a number of device manufacturers willing to make such devices available, including devices and capabilities not yet market approved but appropriate for clinical research. In general it is expected that the devices' existing safety and utility data will be sufficient to enable new IRB NSR or FDA IDE approval without need for significant additional non-clinical data. For more information on the BRAIN PPP, see http://braininitiative.nih.gov/BRAIN_PPP/index.htm

National Institutes of Health

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications to support the validation of molecular/cellular/imaging markers (referred to as "markers" or "biomarkers") and assays for cancer detection, diagnosis, prognosis, monitoring, and prediction of response or resistance to treatment, as well as markers for cancer prevention and control. This FOA will support investigator-initiated research for both analytical, and clinical validation of assays to be used in cancer treatment, control, or prevention trials supported by the NCI. This NOFO will also support the validation of pharmacodynamic markers and markers of toxicity. Applicants should have assays that work on human samples and whose importance is well justified for development into clinical assays. As chemotherapies and/or radiation therapies are increasingly combined with immunotherapies to enhance the durability of anti-cancer responses, assays for measuring multiple markers, including immune markers, can be developed and validated simultaneously. The UH2 phase of this NOFO supports analytical validation of assays for these molecular/cellular/imaging markers, which must be achieved within 2 years before assays may undergo clinical validation. The UH3 phase of this NOFO supports clinical validation of analytically validated assays for up to 3 years using well-annotated biospecimens from retrospective or prospective clinical trials or studies. This NOFO may be used to validate existing assays for use in other cancer clinical trials, observational studies, or population studies. Efforts to harmonize clinical laboratory tests, including investigation into the performance and reproducibility of assays across multiple clinical laboratories, are also appropriate for this funding opportunity. Projects proposed for this NOFO will require multi-disciplinary collaboration among scientific investigators, oncologists, statisticians, and clinical laboratory scientist.

National Institutes of Health

<p>Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate cancer risk and related outcomes (e.g., risk prediction or reduction, survival, or response to treatment, etc.). The goal of this initiative is to address key scientific questions relevant to cancer by supporting the analysis of existing clinical, environmental, surveillance, health services, vital statistics, behavioral, lifestyle, genomic, and molecular profiles data. Applicants are encouraged to leverage and perform innovative analyses of the existing data. Applications may include new research aims that are being addressed with existing data, new or advanced methods of analyses, or novel combinations and integration of datasets that allow the exploration of important scientific questions in cancer research.</p>

National Institutes of Health

<p>The purpose of this NOFO is to invite Research Project (R01) applications that propose to study the ethical, legal, and social implications (ELSI) of human genetics and genomics. Applications may propose studies using either single or mixed methods. Approaches may include but are not limited to empirical qualitative and quantitative methods, as well as conceptual, legal, and normative analyses. Direct involvement of key stakeholders where appropriate is encouraged. This Notice of Funding Opportunity (NOFO) requires a Plan for Enhancing Diverse Perspectives (PEDP) as part of the application. Applications without a PEDP will not be reviewed.</p>

National Institutes of Health

<p>The Office of Disease Prevention (ODP) and participating National Institutes of Health (NIH) Institutes, Centers, and Offices (ICs) are issuing this R01 to solicit applications to address barriers and facilitators that impede use or uptake of cancer screening and preventive services in populations that experience health disparities.&nbsp;</p><p>Interventions should include screening, preventive services, or other healthcare processes, including timely follow-up of abnormal findings, and referral to accessible care. Projects are encouraged to leverage collaborations with community partners and service providers. Interventions should address barriers and facilitators at two or more of the following levels: patient, clinician, healthcare setting, and neighborhood/community. Specific research interests of participating NIH ICs are detailed within.</p>

National Institutes of Health

The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or antagonists of GLP-1, GIP-1, or dual GLP-1/GIP-1 agents) impact cancer risk, and to draw talented scientists who understand the dynamic changes caused by these agents to investigate the mechanisms of how these agents influence cancer risk rather than shorter term outcomes such as weight loss and diabetes. The data thus far suggests that these agents may increase the risk of some, while decreasing the risk of other obesity related cancers.

National Institutes of Health

The goal of this NOFO is to support R21 applications for novel theory and methods development that better delineate how genetic and non-genetic factors contribute to complex trait variation across individuals, families, and populations. Approaches should be interdisciplinary across the natural and social sciences, account for interdependencies across scales of biological, social, and ecological organization, and make extensive use of theory, simulations, and validation using available large-scale datasets

National Institutes of Health

Through this notice of funding opportunity (NOFO), the National Cancer Institute (NCI) invites applications for support of investigator-initiated clinical trials that have the potential to reduce the burden of cancer through improvements in early detection, screening, prevention and interception, healthcare delivery, quality of life, and/or survivorship related to cancer; with such attributes, the proposed studies should also have the potential to improve clinical practice and/or public health. Applications submitted to this NOFO must include studies that meet the National Institutes of Health (NIH) definition of a clinical trial (see NOT-OD-15-015 for details) and provide specific clinical trial information as described in this FOA. This NOFO does not and will not support clinical trials for studies of cancer diagnosis and/or oncologic therapy in patients. The proposed investigator-initiated projects should be related to the programmatic interests of the NCI Division of Cancer Prevention and/or the NCI Division of Cancer Control and Population Sciences.

National Institutes of Health

Through this Notice of Funding Opportunity, the National Cancer Institute (NCI) seeks research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of DCTD and OHAM. The proposed project must involve at least 1 clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program and/or the HIV and AIDS Malignancies Research Programs. Applicants may propose to conduct an early phase trial by itself, or in combination with another research aim(s) as appropriate.

National Institutes of Health

<p>This Notice of Funding Opportunity (NOFO) aims to support research on interdisciplinary population approaches to increasing awareness of the relationship between alcohol and cancer risk, understanding and changing social norms related to alcohol consumption, developing and/or evaluating alcohol policy approaches, and the development, testing, and implementation of population-level interventions to reduce alcohol-related cancer risk. Applications that address multiple levels of consumption, such as moderate and heavy drinking, are of particular interest, as well as those focusing on alcohol use disorder (AUD) from the perspective of cancer prevention and control.</p>

National Institutes of Health

<p>Not available</p>

National Institutes of Health

<p>The purpose of this notice of funding opportunity (NOFO) is to support research on interventions to improve health in Native American (NA) populations. This includes 1) etiologic research, where there is a significant gap in knowledge, that will directly inform intervention development or adaptations, 2) research that develops, adapts, or tests the efficacy or effectiveness of health promotion and disease prevention interventions, 3) research that tests culturally informed treatment or recovery interventions and 4) where a sufficient body of knowledge on intervention efficacy exists, research on dissemination and implementation that develops and tests strategies to overcome barriers to the adoption, integration, scale-up, and sustainability of effective interventions. Existing data suggest that significant acute and chronic disease inequities exist for NA populations. Concurrently, NA populations experience unique sociopolitical, historical, and environmental stressors and risks that may exacerbate health conditions and/or impact the effectiveness of existing solutions to address the conditions. They also possess unique strengths and resiliencies that can mitigate stressors or inform intervention strategies. Through this initiative, intervention and related research is sought to build upon community knowledge, resources, and resilience to test science-based, culturally appropriate solutions to reduce morbidity and mortality through identification and remediation of precursors to diseases and disorders and through culturally informed treatment. Interventions should be designed with a consideration for sustainability within the communities where they are tested, and have the flexibility to be readily adapted, disseminated, and scaled up to other communities where culturally appropriate. For the purposes of this NOFO, NA includes the following populations: Alaska Natives, American Indians (whose ancestral lands fall at least partially within the U.S. main land).</p>

National Institutes of Health

This funding opportunity is part of a suite of NOFOs within the NIH HEAL Initiative to support the development of safe, effective, and non-addictive therapeutics to treat pain. The goal is to encourage initial translational efforts that will support a drug discovery program and advance projects to the point where they meet the entry criteria for the Pain Therapeutics Development Program. The scope will therefore be focused on development of assays to support a distinct testing funnel, screening efforts to identify hits, and initial characterization of hits and potential therapeutic agents (including small molecules, biologics, and natural products).